Thus, the AR-signature expediently included major markers of acute renal failure (STMN1) as well as demonstrated alterations (NME1, Ras-Raf), which have been previously associated with the kidney transplantation specific treatments. This evidence concerns the gene NME1 and acute kidney injury.